HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA class II alleles and multiple sclerosis in Tunisian patients.

AbstractOBJECTIVE:
The aim of our study was to investigate the association of HLA-DRB1 and -DQB1 alleles with multiple sclerosis (MS) in a Tunisian population and their effect on age at onset and disease severity.
METHODS:
58 MS patients and 105 healthy controls were genotyped for HLA class II alleles by PCR-SSP technique.
RESULTS:
An association of MS with HLA-DRB1*15 was found (14.7% vs 3.8%, OR (95% CI)=4.34 (1.69-11.39), p(c)=2.5×10(-3)) after Bonferroni's correction. Moreover, the DRB1*15-DQB1*06 (13.8% vs 2.8%, OR (95% CI)=5.44 (1.92-17.41), p(c)=1.1×10(-3)) and DRB1*04-DQB1*04 (8.6% vs 1.9%, OR (95% CI)=4.86 (1.36-21.62), p(c)=0.028) haplotypes were found to confer a susceptibility to multiple sclerosis.
CONCLUSION:
To our knowledge, this is the first study performed to analyze the association of HLA-DRB1/DQB1 alleles on MS susceptibility in Tunisia. The modern Tunisian gene pool shows some degree of heterogeneity and reflects a significant gene flow from Mediterranean regions.
AuthorsAmira Messadi, Fekih-Mrissa Najiba, Slah Ouerhani, Jemel Zaweli, Ines Louatti, Sami Layouni, Brahim Nciri, Ghaya Bouaicha, Wafa Kouki, Mondher Yedeas, Aly Raies, Ridha Mrissa, Nasreddine Gritli
JournalClinical neurology and neurosurgery (Clin Neurol Neurosurg) Vol. 112 Issue 10 Pg. 849-52 (Dec 2010) ISSN: 1872-6968 [Electronic] Netherlands
PMID20691532 (Publication Type: Journal Article)
CopyrightCopyright © 2010 Elsevier B.V. All rights reserved.
Chemical References
  • HLA-DQ Antigens
  • HLA-DQ beta-Chains
  • HLA-DQB1 antigen
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • HLA-DRB1*15 antigen
Topics
  • Adolescent
  • Adult
  • Age of Onset
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genes, MHC Class II (genetics)
  • Genetic Predisposition to Disease
  • HLA-DQ Antigens (genetics)
  • HLA-DQ beta-Chains
  • HLA-DR Antigens (genetics)
  • HLA-DRB1 Chains
  • Haplotypes
  • Histocompatibility Testing
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis (epidemiology, genetics, pathology)
  • Tunisia (epidemiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: